Preparation method of traditional Chinese medicine for treating qi-stagnation/blood-stasis-type hyperlipemia

Abstract

The invention relates to a preparation method of a traditional Chinese medicine for treating qi-stagnation / blood-stasis-type hyperlipemia, belonging to the technical field of preparation methods of traditional Chinese medicines. The existing method for treating qi-stagnation / blood-stasis-type hyperlipemia generally adopts lipid regulators, and has the defect of great toxic and side effects. The technical scheme is as follows: the preparation method comprises the following steps: taking Akebia trifoliata Koidz, radix curcumae, pomelo, fructus aurantii, immature bitter orange, Chinese anise, murraya jasminorage, aspongopus, sword bean, mysorethorn, cedar, fingered citron, rose, green tangerine orange peel, sundew, trifoliate orange, persimmon clayx, litchi, lychee seed, Mangnolia officinalis, rhizoma cyperi, citron, Semen Aesculi, radix salviae miltiorrhizae, princesplume ladysthumb fruit, motherwort fruit, winged euony twigs, trumpet creeper, hemlock parsley, radix cyathulae, cowherb seed, chinese rose, balsamine, safflower, rhododendra, rape seed, brazilwood, peach kernel, licorice and the like; and soaking the traditional Chinese medicines in water, decocting with soft fire, and filtering to remove slag to obtain liquor, thereby obtaining the traditional Chinese medicine for treating qi-stagnation / blood-stasis-type hyperlipemia. The prepared traditional Chinese medicine has the advantages of small toxic and side effects, short treatment course and high cure rate.

Description

technical field [0001] The invention relates to the technical field of preparation methods of traditional Chinese medicines, in particular to a preparation method of traditional Chinese medicines for treating hyperlipidemia of qi stagnation and blood stasis type. [0002] Background technique [0003] At present, in the treatment of hyperlipidemia of Qi stagnation and blood stasis type, blood lipid-regulating drugs are generally used: [0004] 1. Bezafibrate: ①The most common adverse reactions are gastrointestinal discomfort, such as indigestion, anorexia, nausea, vomiting, and feeling of fullness. ② People who are allergic to this product, suffer from gallbladder disease, cholelithiasis, patients with hepatic insufficiency or primary biliary cirrhosis, patients with severe renal insufficiency, and patients with decreased serum albumin caused by nephrotic syndrome are contraindicated. ③ Pregnant women and lactating women should use it with caution. [0005] 2. Acipimox: ①...

AI Technical Summary

Problems solved by technology

[0008] 5. Fluvastatin: ① The adverse reaction is mild and short-lived dyspepsia

③ This product interferes with the diagnosis: a. Hemoglobin, hematocrit, and white blood cell count may decrease

④ Poor curative effect on homozygous familial hypercholesterolemia

Due to the complete lack of low-density lipoprotein (LDL) receptors in patients with homozygous familial hypercholesterolemia, simvastatin is less effective in these patients

Images